🇺🇸 FDA
Patent

US 10188739

Compositions and methods for administering insulin or insulin-like protein to the brain

granted A61KA61K38/28A61K47/61

Quick answer

US patent 10188739 (Compositions and methods for administering insulin or insulin-like protein to the brain) held by XENETIC BIOSCIENCES, INC. expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
XENETIC BIOSCIENCES, INC.
Grant date
Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/28, A61K47/61, A61K9/0043